Enovix Corp. (ENVX)

NASDAQIndustrialsElectrical Equipment & PartsSnapshot 2026-10-23

$2.79+9.41%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Enovix Corp.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q3
Revenue	$9M–$10M	—
FY 2026 · Q4
Revenue	—	12.51M
EPS	—	-0.149
FY 2026 · Annual
Revenue	—	38.73M
EPS	—	-0.564
FY 2027 · Annual
Revenue	—	75.77M
EPS	—	-0.59

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Capital spending near $11 million in Q2 2026	It aims to keep capital spending near $11 million next quarter.	Intact	Capital expenditures rise above $13 million or fall below $9 million in Q2 2026	Capital expenditures: $9.624M FY2026-Q2; GAAP. Published target: ~$11 million. The target does not explicitly identify fiscal versus calendar quarters. Source published Aug 12, 20269,624,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jul 5, 2026 Source: stock_quarterly_financials_fmp. Reference: 2026-Q2. Source status: unverified. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Gross profit of at least $1.55 million in Q1 2026	Gross profit improved to $1.55 million in Q1 2026.	Under Pressure	Gross profit falls below $1.4 million in Q1 2026	Gross profit: $1.302M FY2026-Q2; GAAP. Published target: >= $1.55 million. The stored target says 2026-Q1; this source reports FY2026-Q2. Fiscal/calendar alignment needs review. Source published Aug 12, 20261,302,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jul 5, 2026 Source: company_financial_results. Reference: 117f9d96-52de-442c-8c4e-c03213802817. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Revenue of about $8.5 million in Q2 2026	A primary condition in Enovix Corp.'s published investment case. The stated target is ~$8.5 million.	Broken	Revenue falls below $8.0 million in Q2 2026	Revenue: $9.024M FY2026-Q2; GAAP. Published target: ~$8.5 million. The target does not explicitly identify fiscal versus calendar quarters. Source published Aug 12, 20269,024,000 USD · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jul 5, 2026 Source: company_financial_results. Reference: 117f9d96-52de-442c-8c4e-c03213802817. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-28 · fmp

FY2027 EPS$-0.59

$-0.57 → $-0.59 · observed estimates

FY2027 revenue$0.08B

$0.09B → $0.08B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$-0.57	$91,143,985	7 / 9
2026-07-25	$-0.57	$91,143,985	7 / 9
2026-07-26	$-0.57	$91,143,985	8 / 9
2026-07-27	$-0.57	$91,143,985	8 / 9
2026-07-28	$-0.57	$91,142,030	8 / 9
2026-07-29	$-0.57	$91,142,030	8 / 9
2026-07-30	$-0.57	$91,142,030	8 / 9
2026-07-31	$-0.57	$91,142,030	8 / 9
2026-08-01	$-0.57	$91,142,030	8 / 9
2026-08-02	$-0.57	$91,142,030	8 / 9
2026-08-03	$-0.57	$91,142,030	8 / 9
2026-08-04	$-0.57	$91,142,030	8 / 9
2026-08-05	$-0.57	$91,142,030	8 / 9
2026-08-06	$-0.57	$91,142,030	8 / 9
2026-08-07	$-0.57	$91,142,030	8 / 9
2026-08-08	$-0.57	$91,142,030	8 / 9
2026-08-09	$-0.57	$91,142,030	8 / 9
2026-08-10	$-0.57	$91,142,030	8 / 9
2026-08-11	$-0.57	$91,142,030	8 / 9
2026-08-12	$-0.57	$91,142,030	8 / 9
2026-08-13	$-0.57	$91,142,030	8 / 9
2026-08-14	$-0.57	$91,142,030	8 / 9
2026-08-15	$-0.57	$91,142,030	8 / 9
2026-08-16	$-0.57	$91,142,030	7 / 9
2026-08-17	$-0.57	$91,142,030	7 / 9
2026-08-18	$-0.57	$91,142,030	7 / 9
2026-08-19	$-0.57	$91,142,030	8 / 9
2026-08-20	$-0.59	$77,396,020	7 / 9
2026-08-21	$-0.59	$77,396,020	7 / 9
2026-08-22	$-0.59	$75,313,840	7 / 9
2026-08-23	$-0.59	$75,313,840	7 / 9
2026-08-24	$-0.59	$75,313,840	7 / 9
2026-08-25	$-0.59	$75,317,386	7 / 9
2026-08-26	$-0.59	$75,317,386	7 / 9
2026-08-27	$-0.59	$75,317,386	7 / 9
2026-08-28	$-0.59	$75,317,386	7 / 9
2026-08-29	$-0.59	$75,317,386	7 / 9
2026-08-30	$-0.59	$75,317,386	7 / 9
2026-08-31	$-0.59	$75,317,386	7 / 9
2026-09-01	$-0.59	$75,317,386	7 / 9
2026-09-02	$-0.59	$75,317,386	7 / 9
2026-09-03	$-0.59	$75,317,386	7 / 9
2026-09-04	$-0.59	$75,317,386	7 / 9
2026-09-05	$-0.59	$75,317,386	7 / 9
2026-09-06	$-0.59	$75,317,386	7 / 9
2026-09-07	$-0.59	$75,317,386	7 / 9
2026-09-08	$-0.59	$75,317,386	7 / 9
2026-09-09	$-0.59	$75,317,386	7 / 9
2026-09-10	$-0.59	$75,317,386	7 / 9
2026-09-11	$-0.59	$75,317,386	7 / 9
2026-09-12	$-0.59	$75,317,386	7 / 9
2026-09-13	$-0.59	$75,317,386	7 / 9
2026-09-14	$-0.59	$75,317,386	7 / 9
2026-09-15	$-0.59	$75,317,386	7 / 9
2026-09-16	$-0.59	$75,317,386	7 / 9
2026-09-17	$-0.59	$75,317,386	7 / 9
2026-09-18	$-0.59	$75,317,386	7 / 9
2026-09-19	$-0.59	$75,317,386	7 / 9
2026-09-20	$-0.59	$75,317,386	7 / 9
2026-09-21	$-0.59	$75,317,386	7 / 9
2026-09-22	$-0.59	$75,317,386	7 / 9
2026-09-23	$-0.59	$75,317,386	7 / 9
2026-09-24	$-0.59	$75,317,386	7 / 9
2026-09-25	$-0.59	$75,317,386	7 / 9
2026-09-26	$-0.59	$75,317,386	7 / 9
2026-09-27	$-0.59	$75,317,386	7 / 9
2026-09-28	$-0.59	$75,317,386	7 / 9
2026-09-29	$-0.59	$75,317,386	7 / 9
2026-09-30	$-0.59	$75,317,386	7 / 9
2026-10-01	$-0.59	$75,317,386	7 / 9
2026-10-02	$-0.59	$75,317,386	7 / 9
2026-10-03	$-0.59	$75,317,386	7 / 9
2026-10-04	$-0.59	$75,318,122	7 / 9
2026-10-05	$-0.59	$75,318,122	7 / 9
2026-10-06	$-0.59	$75,318,122	7 / 9
2026-10-07	$-0.59	$75,318,122	7 / 9
2026-10-08	$-0.59	$75,318,122	7 / 9
2026-10-09	$-0.59	$75,318,122	7 / 9
2026-10-10	$-0.59	$75,318,122	7 / 9
2026-10-11	$-0.59	$75,599,945	8 / 10
2026-10-12	$-0.59	$75,599,945	8 / 10
2026-10-13	$-0.59	$75,599,945	8 / 10
2026-10-14	$-0.59	$75,766,612	8 / 10
2026-10-15	$-0.59	$75,766,612	8 / 10
2026-10-16	$-0.59	$75,766,612	8 / 10
2026-10-17	$-0.59	$75,766,612	8 / 10
2026-10-18	$-0.59	$75,766,612	8 / 10
2026-10-19	$-0.59	$75,766,612	8 / 10
2026-10-20	$-0.59	$75,766,612	8 / 10
2026-10-21	$-0.59	$75,766,612	8 / 10
2026-10-22	$-0.59	$75,766,612	8 / 10
2026-10-23	$-0.59	$75,766,612	8 / 10
2026-10-24	$-0.59	$75,766,612	8 / 10

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	9	3	1
2026-06-01	9	2	1
2026-07-01	9	2	1
2026-08-01	9	3	1
2026-09-01	9	3	1
2026-10-01	8	3	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 8 Buy / Strong Buy · 3 Hold · 1 Sell / Strong Sell

0 upgrades0 downgrades1 maintains

Recent actions · Sep 25–Oct 24 · 1 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Northland SecuritiesOct 13

$5.00New observation · no comparable prior

$0$2.75$5.50

0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Capital spending near $11 million in Q2 2026Capital expenditures: $9.624M
Gross profit of at least $1.55 million in Q1 2026Published status: Under Pressure
Revenue of about $8.5 million in Q2 2026Published status: Broken

Next proof point

Nov 4, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

3.3%Typical daily move · historical

Downside history

-81.7%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Enovix Corp. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a high-risk, speculative growth business, not a proven compounder: it remains loss-making and recent financial performance is weak. The long-term thesis is still in the watch stage, with execution progress in some markets but mixed evidence on production ramps and volatile management signals.

What's priced into Enovix Corp.

ENVX trades at a substantial premium to peers, and the valuation model has low confidence. The market appears to assign value to future opportunities, but the evidence does not establish that commercial scale or profitability is assured; the priced-in assessment flags the valuation as unjustified, though overall fragility is rated low.

What the fundamentals likely do

Near term, the 2026-10-13 earnings beat is a positive update, but the broader record remains weak and the thesis signal recently changed from mixed to cautious. Smartphone battery qualification is on track, with revenue and non-GAAP gross margin improving over the reported period, while smart eyewear production is mixed; drone and defense pipeline growth and capacity investment are on track. A management transition and newly filed litigation add uncertainty, and the next guidance update is an important risk.

What Enovix Corp. hinges on

Over the next several quarters, the key test is whether smartphone battery qualification leads to commercial production and whether smart eyewear shipments expand as planned. Continued growth in drone, defense, and industrial demand would support execution, while a guidance cut would be a meaningful setback. Industrials-sector momentum may also depend on whether bellwethers ETN, VRT, and BE continue to report strong results and guidance.

Bottom line

For a 1-3 year view, ENVX has real execution milestones and expanding market pipelines, but remains loss-making, high risk, and expensive relative to peers, with limited confidence in the valuation assessment. The thesis turns on converting progress into sustained commercial scale and maintaining guidance. Not investment advice.

Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.

Measure / period	Management expectations	Analyst expectations
FY 2026 · Q3
Revenue	$9M–$10M	—
FY 2026 · Q4
Revenue	—	12.51M
EPS	—	-0.149
FY 2026 · Annual
Revenue	—	38.73M
EPS	—	-0.564
FY 2027 · Annual
Revenue	—	75.77M
EPS	—	-0.59

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-28 · fmp

FY2027 EPS$-0.59

$-0.57 → $-0.59 · observed estimates

FY2027 revenue$0.08B

$0.09B → $0.08B · observed estimates

Exact estimates & source dates

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$-0.57	$91,143,985	7 / 9
2026-07-25	$-0.57	$91,143,985	7 / 9
2026-07-26	$-0.57	$91,143,985	8 / 9
2026-07-27	$-0.57	$91,143,985	8 / 9
2026-07-28	$-0.57	$91,142,030	8 / 9
2026-07-29	$-0.57	$91,142,030	8 / 9
2026-07-30	$-0.57	$91,142,030	8 / 9
2026-07-31	$-0.57	$91,142,030	8 / 9
2026-08-01	$-0.57	$91,142,030	8 / 9
2026-08-02	$-0.57	$91,142,030	8 / 9
2026-08-03	$-0.57	$91,142,030	8 / 9
2026-08-04	$-0.57	$91,142,030	8 / 9
2026-08-05	$-0.57	$91,142,030	8 / 9
2026-08-06	$-0.57	$91,142,030	8 / 9
2026-08-07	$-0.57	$91,142,030	8 / 9
2026-08-08	$-0.57	$91,142,030	8 / 9
2026-08-09	$-0.57	$91,142,030	8 / 9
2026-08-10	$-0.57	$91,142,030	8 / 9
2026-08-11	$-0.57	$91,142,030	8 / 9
2026-08-12	$-0.57	$91,142,030	8 / 9
2026-08-13	$-0.57	$91,142,030	8 / 9
2026-08-14	$-0.57	$91,142,030	8 / 9
2026-08-15	$-0.57	$91,142,030	8 / 9
2026-08-16	$-0.57	$91,142,030	7 / 9
2026-08-17	$-0.57	$91,142,030	7 / 9
2026-08-18	$-0.57	$91,142,030	7 / 9
2026-08-19	$-0.57	$91,142,030	8 / 9
2026-08-20	$-0.59	$77,396,020	7 / 9
2026-08-21	$-0.59	$77,396,020	7 / 9
2026-08-22	$-0.59	$75,313,840	7 / 9
2026-08-23	$-0.59	$75,313,840	7 / 9
2026-08-24	$-0.59	$75,313,840	7 / 9
2026-08-25	$-0.59	$75,317,386	7 / 9
2026-08-26	$-0.59	$75,317,386	7 / 9
2026-08-27	$-0.59	$75,317,386	7 / 9
2026-08-28	$-0.59	$75,317,386	7 / 9
2026-08-29	$-0.59	$75,317,386	7 / 9
2026-08-30	$-0.59	$75,317,386	7 / 9
2026-08-31	$-0.59	$75,317,386	7 / 9
2026-09-01	$-0.59	$75,317,386	7 / 9
2026-09-02	$-0.59	$75,317,386	7 / 9
2026-09-03	$-0.59	$75,317,386	7 / 9
2026-09-04	$-0.59	$75,317,386	7 / 9
2026-09-05	$-0.59	$75,317,386	7 / 9
2026-09-06	$-0.59	$75,317,386	7 / 9
2026-09-07	$-0.59	$75,317,386	7 / 9
2026-09-08	$-0.59	$75,317,386	7 / 9
2026-09-09	$-0.59	$75,317,386	7 / 9
2026-09-10	$-0.59	$75,317,386	7 / 9
2026-09-11	$-0.59	$75,317,386	7 / 9
2026-09-12	$-0.59	$75,317,386	7 / 9
2026-09-13	$-0.59	$75,317,386	7 / 9
2026-09-14	$-0.59	$75,317,386	7 / 9
2026-09-15	$-0.59	$75,317,386	7 / 9
2026-09-16	$-0.59	$75,317,386	7 / 9
2026-09-17	$-0.59	$75,317,386	7 / 9
2026-09-18	$-0.59	$75,317,386	7 / 9
2026-09-19	$-0.59	$75,317,386	7 / 9
2026-09-20	$-0.59	$75,317,386	7 / 9
2026-09-21	$-0.59	$75,317,386	7 / 9
2026-09-22	$-0.59	$75,317,386	7 / 9
2026-09-23	$-0.59	$75,317,386	7 / 9
2026-09-24	$-0.59	$75,317,386	7 / 9
2026-09-25	$-0.59	$75,317,386	7 / 9
2026-09-26	$-0.59	$75,317,386	7 / 9
2026-09-27	$-0.59	$75,317,386	7 / 9
2026-09-28	$-0.59	$75,317,386	7 / 9
2026-09-29	$-0.59	$75,317,386	7 / 9
2026-09-30	$-0.59	$75,317,386	7 / 9
2026-10-01	$-0.59	$75,317,386	7 / 9
2026-10-02	$-0.59	$75,317,386	7 / 9
2026-10-03	$-0.59	$75,317,386	7 / 9
2026-10-04	$-0.59	$75,318,122	7 / 9
2026-10-05	$-0.59	$75,318,122	7 / 9
2026-10-06	$-0.59	$75,318,122	7 / 9
2026-10-07	$-0.59	$75,318,122	7 / 9
2026-10-08	$-0.59	$75,318,122	7 / 9
2026-10-09	$-0.59	$75,318,122	7 / 9
2026-10-10	$-0.59	$75,318,122	7 / 9
2026-10-11	$-0.59	$75,599,945	8 / 10
2026-10-12	$-0.59	$75,599,945	8 / 10
2026-10-13	$-0.59	$75,599,945	8 / 10
2026-10-14	$-0.59	$75,766,612	8 / 10
2026-10-15	$-0.59	$75,766,612	8 / 10
2026-10-16	$-0.59	$75,766,612	8 / 10
2026-10-17	$-0.59	$75,766,612	8 / 10
2026-10-18	$-0.59	$75,766,612	8 / 10
2026-10-19	$-0.59	$75,766,612	8 / 10
2026-10-20	$-0.59	$75,766,612	8 / 10
2026-10-21	$-0.59	$75,766,612	8 / 10
2026-10-22	$-0.59	$75,766,612	8 / 10
2026-10-23	$-0.59	$75,766,612	8 / 10
2026-10-24	$-0.59	$75,766,612	8 / 10

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings